Endo Pharmaceutical may have gotten a pass on the latest testosterone side effects trial, but its problems are far from resolved. The drug company faces nearly 1,300 lawsuits involving its testosterone replacement therapy Testim, as well as other testosterone products it markets, in state and federal courts. Endo faced the third trial in a class action lawsuit against several manufacturers of testosterone treatments over claims that the drugs caused cardiovascular side effects including heart attacks, strokes, blood clots and death. The first two trials were waged against AbbVie Inc., maker of the blockbuster testosterone treatment AndroGel, and resulted in verdicts ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.